In cooperation with researchers from the US, Israel and Europe, the Netherlands Cancer Institute (Antoni van Leeuwenhoek) has developed a new immune therapy for metastasised melanoma. During the next four years, the therapy will be available in research context and covered by health insurance. Continue reading
Showing articles tagged with 'Melanoma'
In advanced melanoma patients who do not benefit from existing therapies, personalised anti-cancer vaccines may help in the future. The first test of individual immunotherapie in three melanoma patients achieved good results. The American scientists measured an increase in number and diversity of cancer-fighting T cells, the publication in Science Express shows. Continue reading